SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Chandrashekar, Abishek, Liu, Jinyan, Martinot, Amanda J., McMahan, Katherine, Mercado, Noe B., Peter, Lauren, Tostanoski, Lisa H., Yu, Jingyou +45 more·2020·Science
DOI 10.1126/science.abc4776

Cited by (785)

Items 701–785 of 785

  1. Pathological characteristics of SARS-CoV-2 variants and immune responses induced in a COVID-19 macaque model
    Emiko Urano, Tomotaka Okamura, Mahoko Higuchi, Mugi Furukawa, Kayoko Ueda, Satoshi Nagata, Haruhiko Kamada, Yasuhiro Yasutomi · 2026 · Communications Biology
  2. Immunogenicity of Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Versus Non-Adjuvanted SARS-CoV-2 Spike Booster Vaccines in Young and Aged Balb/c Mice
    Felicity C. Stark, Bassel Akache, Tyler M. Renner, Gerard Agbayani, L. Deschatelets, Renu Dudani, Blair A. Harrison, U. Hemraz, Sophie Régnier, M. Stuible et al. · 2025 · Vaccines
  3. Modeling Virus-Associated Central Nervous System Disease in Non-Human Primates
    Krystal J. Vail, Brittany N Macha, L. Hellmers, Tracy Fischer · 2025 · International Journal of Molecular Sciences
  4. Protective efficacy of pDNA vaccine candidate against SARS-CoV-2 in Syrian golden hamsters
    Iman Almansour-Alzamil, S. Golovan, Jennifer A. Pickens, Krista Salley, Michael Roberts · 2025 · Journal of drug targeting (Print)
  5. Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection
    Nikolas Weigl, C. Pleimelding, Leonard Gilberg, D. Huynh, Isabel Brand, Jan Bruger, Jonathan Frese, T. Eser, Mohamed I. M. Ahmed, Jessica M. Guggenbuehl-Noller et al. · 2025 · PLoS ONE
  6. [Acute respiratory viral infections in monkeys].
    D. I. Dogadov, K. Kyuregyan, A. A. Minosyan, A. M. Goncharenko, Elena V. Shmat, M. I. Mikhailov · 2025 · Voprosy virusologii
  7. Protocol for evaluating humoral immune responses in mice following SARS-CoV-2 vaccination
    Yao Zhang, Shixiong Li, Jing-You Yu · 2025 · STAR Protocols
  8. Proceedings of the 2023 Division of Translational Toxicology Satellite Symposium
    E. Quist, R. Chamanza, A. Martinot, Allison C Boone, G. Krane, M. Hensel, Shawndrea Lennix · 2023 · Toxicologic pathology (Print)
  9. PCR data accurately predict infectious virus: a characterization of SARS-CoV-2 in non-human primates
    Celine E. Snedden, J. Lloyd-Smith · 2023 · bioRxiv
  10. Animal models and SARS-CoV-2-induced pulmonary and neurological injuries
    M. Pinto, Alexandre Dos Santos da Silva, Daniela del Rosário Flores Rodrigues, Rodrigo Müller, Gentil Arthur Lins Bentes Mendonça de Vasconcelos, Patrícia Cristina da Costa Neves, J. D. De Oliveira, R. Marchevsky · 2023 · Memórias do Instituto Oswaldo Cruz
  11. A genetically engineered, stem-cell-derived cellular vaccine
    Amanda Cooper, Adam Sidaway, Abishek Chandrashekar, Elizabeth Latta, Krishnendu Chakraborty, Jingyou Yu, Katherine McMahan, Victoria M. Giffin, Cordelia Manickam, Kyle W. Kroll et al. · 2022 · Cell Reports Medicine
  12. Dam-infant rhesus macaque pairs to dissect age-dependent responses to SARS-CoV-2 infection
    S. Langel, C. Garrido, C. Phan, Tatianna Travieso, H. Kirshner, Todd Demarco, Zhong-Min Ma, J. Reader, K. Olstad, R. Sammak et al. · 2022 · ImmunoHorizons
  13. Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
    Wen-Xin Wang, R. Jia, Jin-Wen Song, Xiao-Ning Zhang, Shuang Zhou, Fuzhen Wang, Jun-Liang Fu · 2022 · Frontiers in Microbiology
  14. A Case Series of SARS-CoV-2 Reinfection in Elite Athletes
    G. Fülöp, B. Lakatos, M. Ruppert, A. Kovács, V. Juhász, G. Dér, A. Tállay, H. Vágó, B. Kiss, B. Merkely et al. · 2022 · International Journal of Environmental Research and Public Health
  15. Nanoarchitectonics: role of nanomaterials in vaccination strategies for curbing SARs-CoV-2/COVID-19
    I. Zulfiqar, Abdul Wahab, M. U. Saeed, Nazim Hussain, M. Sabar, M. Bilal, Hafiz M.N. Iqbal · 2022 · Nanofabrication
  16. Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2
    George Ssenyange, M. Kerfoot, Min Zhao, S. Farhadian, Si-Di Chen, Lei Peng, Ping Ren, C. Dela Cruz, Shaili Gupta, Richard E. Sutton · 2022 · Cell Reports Methods
  17. Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
    M. Hernández-Porto, Sagrario García, T. Delgado, Yaiza Rodriguez, A. Aguirre-Jaime, S. Campos, Cintia Hernández, C. Lorenzo, M. Lecuona · 2022 · International Journal of Infectious Diseases
  18. Patients at risk of pulmonary fibrosis Post Covid-19: Epidemiology, pulmonary sequelaes and humoral response
    M. H. Porto, T. Delgado, A. Aguirre-Jaime, M. J. Ramos, S. Campos, O. Acosta, A. Llanos, M. Lecuona · 2022 · medRxiv
  19. Human Challenge Studies with Coronaviruses Old and New.
    Richard Mckendry, N. Lemm, Loukas Papargyris, C. Chiu · 2022 · Current Topics in Microbiology and Immunology
  20. Distinct upper airway epithelium interferon-stimulated and profibrotic gene expression between adult and infant rhesus macaques infected with SARS-CoV-2
    S. Langel, C. Garrido, C. Phan, Tatianna Travieso, Todd Demarco, Zhong-Min Ma, Rachel J. Reader, K. Olstad, R. Sammak, Y. S. Lakshmanappa et al. · 2022 · bioRxiv
  21. Experimental Models of SARS-COV-2 Infection in the Central Nervous System
    Annamaria Paoletti, M. Melilli, Immacolata Vecchio · 2022 · Journal of Central Nervous System Disease
  22. Myeloid cell-driven nonregenerative pulmonary scarring is conserved in multiple nonhuman primate species regardless of SARS-CoV-2 infection modality
    A. Fears, B. Beddingfield, Nicole R. Chirichella, Nadia Slisarenko, S. Killeen, R. Redmann, K. Goff, Skye Spencer, Breanna Picou, Nadia A. Golden et al. · 2021 · bioRxiv
  23. Efficacy of POC Antibody Assays after COVID-19 Infection and Potential Utility for “Immunity Passports”
    A. Shalaby, H. Laharwani, J. Bates, P. Kyle · 2021 · Laboratoriums Medizin
  24. Recurrent SARS-CoV-2 RNA positivity and prolonged viral shedding in a patient with COVID-19: a case report
    Chunfang Xiao, Lin-Fa Chen, You Li · 2021 · BMC Infectious Diseases
  25. A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in rhesus macaques
    Ronald R. Cobb, Joseph P. Nkolola, P. Gilchuk, A. Chandrashekar, R. V. House, Christopher G. Earnhart, N. Dorsey, Svetlana A. Hopkins, Doris M. Snow, Rita E. Chen et al. · 2021 · bioRxiv
  26. Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 and Spike Protein Subunit 1
    T. Cory, R. Emmons, Johnathan R. Yarbro, Kierstin L. Davis, Brandt D. Pence · 2021 · bioRxiv
  27. Brain and Lung Cross-Protection against Ancestral or Emerging SARS-CoV-2 by Intranasal Lentiviral Vaccination in a New hACE2 Transgenic Murine Model
    Min-Wen Ku, Pierre Authié, M. Bourgine, François Anna, Amandine Noirat, Fanny Moncoq, B. Vesin, Fabien Névo, Jodie Lopez, P. Souque et al. · 2021 · Research Square
  28. Reinfección por SARS-CoV-2
    I. Romera, K. Núñez, M. Calizaya, I. Baeza, R. Molina, J. Morillas · 2021 · Medicina Intensiva
  29. Reinfecção por COVID-19: Uma revisão das novas evidências
    Wellington Manoel da Silva, M. D. Da Silva, Jociéllen Maria Gomes de Lima, Analice Pereira Canejo Ferreira, Francisca Vanessa de Oliveira, K. A. D. de Souza, Juliana Figueira de Carvalho Pereira, Jardeson Joaquim Bezerra, Marks Passos Santos, Williane Karine Lira Barros da Silva et al. · 2021
  30. Biological Significance of Anti–SARS-CoV-2 Antibodies
    N. Manouchehri, L. Steinman, O. Stüve · 2020 · Neurology: Neuroimmunology & Neuroinflammation
  31. Whither immunity? The search for effective, durable immunity to coronavirus disease 2019 (COVID-19)
    D. Henderson, Sarah D. Haessler, M. Hayden, David J Weber, H. Babcock, Anurag N. Malani, Sharon B. Wright, A. R. Murthy, Judith A. Guzman-Cottrill, C. Rock et al. · 2020 · Infection control and hospital epidemiology
  32. Sérologie du SRAS-CoV-2 (COVID-19) : Répercussions sur la pratique clinique, la médecine de laboratoire et la santé publique
    P. Van Caeseele, D. Bailey, S. Forgie, T. Dingle, M. Krajden · 2020 · Canadian Medical Association Journal
  33. Serology profile and effects of influenza vaccination on COVID-19-positive symptomatic and asymptomatic patients
    Allison N. Grossberg, Lilia A. Koza, Aurélie Ledreux, C. Prusmack, H. Krishnamurthy, V. Jayaraman, A. Granholm, D. Linseman · 2020
  34. A Standard Virus Load Function
    T. Hillen · 2020 · medRxiv
  35. COVID-19 Pandemic Panic: Prophylactic as Well as Therapeutic Management with Traditional Ethnic Phytopharmaceuticals with Challenging Nano-spray Inhaler and Advanced Drug Delivery System
    Gaurav K Gupta, A. Bhattacharjee, A. Ladha, Adity Sarbajna, P. Palit, S. Mandal · 2021 · Medicinal Plants for Lung Diseases
  36. From aerosol to alveoli: materials, methods, and models to bridge barriers to respiratory delivery of RNA
    S. Chien, Beth L. Laube, R. Vehring, Emily A. Voigt, David J. Peeler · 2026 · Frontiers in Immunology
  37. Exposure route, not dose, is the primary driver of infection patterns for a respiratory virus
    Celine E. Snedden, Dylan H. Morris, T. C. Friedrich, J. O. Lloyd-Smith · 2026 · Science Advances
  38. Rethinking non-human primate models for emerging viral infections after COVID-19
    Dong-Yeon Kim, J. Hong · 2026 · Laboratory Animal Research
  39. Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters
    Hong-Su Park, Yumiko Matsuoka, Celia Santos, Eleanor F. Duncan, Jaclyn A. Kaiser, Li-Juan Yang, Cindy Luongo, Xue-Qiao Liu, I-Ting Teng, Peter D. Kwong et al. · 2026 · Journal of Virology
  40. Immunopathologic Evaluation of E. Coli Adjuvant Proteins Conjugated with ZnO Nanoparticles in Young Lambs
    Hassan H. K. Al-Bayati, T. Shihab, Ahmed Abdullah Sultan, B. Noomi, Qusai Saleh Jumaa, J. M. Suleiman · 2026 · Tikrit Journal for Agricultural Sciences
  41. Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters
    Hong-Su Park, Yumiko Matsuoka, Celia Santos, Eleanor F. Duncan, Jaclyn A. Kaiser, Li-Juan Yang, Cindy Luongo, Xue-Qiao Liu, I-Ting Teng, Peter D. Kwong et al. · 2025 · bioRxiv
  42. Comparative single-cell immune responses in peripheral blood and lymph node of immunized SARS-CoV-2 challenged infant rhesus macaques
    S. Anronikov, Cameron Meikle, Emma C. Milligan, Han Chen, Nilanjan Mukherjee, Zach Bjornson, B. Gaudilliere, Si-Zun Jiang, S. Permar, K. V. van Rompay et al. · 2025 · Frontiers in Immunology
  43. Paternity testing for crab‐eating macaques and rhesus macaques using microsatellite markers
    Yiming Yuan, Tianqi Sun, Lu Zhang, Wensheng Zhang, Teng Meng, Jianhua Zheng, Rui Zhang, Lei Lu, Z. Pu, Yan Li et al. · 2025 · Animal Models and Experimental Medicine
  44. Changes in peripheral blood mononuclear cell electrical properties in response to viral exposure and vaccination
    Krista S. P. Clarke, Alexander T. Stewart, Emma L. Sinclair, Rebecca Lewis, Fatima Hanna Labeed, Deborah K. Dunn‐Walters, Michael Pycraft Hughes · 2025 · Scientific Reports
  45. When Less Is Statistically Equivalent: Lobe-Specific Optimization of Histopathological Assessment in SARS-CoV-2 Pneumonia
    Rachel J. Reader, Lincoln Hopkins, K. V. van Rompay, K. Olstad, Amir Ardeshir · 2025 · Comput. Biol. Medicine
  46. Antibody response after SARS-CoV-2 infection or vaccination in China: A cross-sectional study
    Peng Zhu, Yan Chen, Xia Xu, Deyong Tan, Li Xiao, Cheng-Ling Liao, Huan Xia, Ting Zhang, Jing Zou, Xuan Chen et al. · 2025 · Vaccine X
  47. Assessment of post-COVID-19 vaccination neutralizing antibodies in kidney transplant and hemodialysis patients versus the general population
    I. Sarhan, M. Abdelgawad, A. Emara, Moaaz A.A. Elkader, Ahmed F. Mohamed · 2024 · Journal of The Egyptian Society of Nephrology and Transplantation
  48. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques
    Jaclyn A. Kaiser, Christine E. Nelson, Xue-Qiao Liu, Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, Celia Santos, Laura R. H. Ahlers, Richard Herbert, Ian N. Moore et al. · 2024 · Nature Communications
  49. Clinical characteristics, management, and prevention of coronavirus disease 2019
    Wei‐jie Guan, Jianxing He · 2023 · Frigid Zone Medicine
  50. Neutralizing Antibodies against SARS-CoV2
    Prachi V. Athavale, V. Athavale, P. Suryawanshi, K. Khillare, Srikanth Tripathy · 2023 · Medical Journal of Dr. D.Y. Patil Vidyapeeth
  51. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
    J. G. Diego, Gagandeep Singh, S. Jangra, Kim Handrejk, M. Laporte, Lauren A. Chang, S. E. El Zahed, L. Pache, Max W. Chang, Prajakta Warang et al. · 2023 · bioRxiv
  52. Upper Respiratory Infection Drives Clinical Signs and Inflammatory Responses Following Heterologous Challenge of SARS-CoV-2 Variants of Concern in K18 Mice
    Jacob H. Nichols, Evan Peter Williams, Jyothi Parvathareddy, Xueyuan Cao, Ying Kong, Elizabeth Ann Fitzpatrick, Richard J. Webby, Colleen Beth Jonsson · 2023 · Viruses
  53. D614G SARS-CoV-2 Pseudovirus Infectivity and Binding of Spike Protein to the ACE2 Receptor Inversely Correlates with Serum SARS-CoV-2-Specific IgG Levels
    L. McCullagh, N. Sheehy, C. De Gascun, J. Hassan · 2023 · Viral immunology
  54. Mice Humanized for Major Histocompatibility Complex and Angiotensin-Converting Enzyme 2 with High Permissiveness to SARS-CoV-2 Omicron Replication
    F. le Chevalier, Pierre Authié, Sébastien Chardenoux, M. Bourgine, B. Vesin, Delphine Cussigh, Y. Sassier, I. Fert, Amandine Noirat, K. Nemirov et al. · 2022 · bioRxiv
  55. SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta): Monitoring and efficacy
    Dan Qi Priscilla Oh, I. Grothe, Herbert Lukaß, A. Kreiter, M. Hoffmann, D. Wegener · 2022 · bioRxiv
  56. The Flow Cytometry Study of Cellular Immunity in Rhesus Monkeys after Experimental Infection with SARS CoV 2 Virus
    G. Borisevich, S. L. Kirillova, I. V. Shatokhina, V. Lebedev, S. S. Solov’ev, S. Syromyatnikova, N. Shagarova, N. Boyarskaya, N. G. Levkovich, D. A. Solyanik et al. · 2022 · Problems of Particularly Dangerous Infections
  57. Screening of field-caught mosquitoes for the SARS-CoV-2 virus at the southwest of Saudi Arabia
    Y. Alraey, G. Zaman, S. Alhefdi, Roaa A. Asiri, S. Alshehri, S. Alasmari, A. Hakami, A. Saeed, A. Dera · 2022 · King Khalid University Journal of Health Sciences
  58. Special focus on SARS-CoV-2 and other zoonotic respiratory coronaviruses in animal models
    H. Adissu, D. Meyerholz, Amanda J. Martinot, J. Ward · 2022 · Veterinary Pathology-Supplement
  59. An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques
    Patrick Madden, Y. Thomas, R. Blair, S. Samer, Mark Doyle, C. Midkiff, L. Doyle-Meyers, Mark E. Becker, M. S. Arif, Michael D. McRaven et al. · 2022 · bioRxiv
  60. Immunology in COVID-19; more than diagnosis of infection or the basis of vaccination
    Natalia Egri, Manel Juan · 2022 · Medicina Clínica (English Edition)
  61. An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa
    B. Vesin, Jodie Lopez, Amandine Noirat, Pierre Authié, I. Fert, F. le Chevalier, Fanny Moncoq, K. Nemirov, C. Blanc, C. Planchais et al. · 2022 · bioRxiv
  62. Novel universal SARS-CoV DNA vaccine inducing neutralizing antibodies to huCoV-19/WH01, Beta, Delta and Omicron variants and T cells to Bat-CoV
    K. S. Appelberg, G. Ahlén, Negin Nikoyan, Jing-Yi Yan, S. Weber, O. Larsson, U. Höglund, Soo Aleman, F. Weber, Emma Perlhamre et al. · 2022 · Research Square
  63. State-of-the-art preclinical evaluation of COVID-19 vaccine candidates
    Devlina Ghosh, Bing-Xin Bai, Qun Ji, S. Palliyil, Guang Yang, Alok Kumar, A. Saxena · 2021 · Exploration of Immunology
  64. SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccines
    Marie Alexandre, R. Marlin, M. Prague, Séverin Coléon, Nidhal Kahlaoui, Sylvain Cardinaud, Thibaut Naninck, B. Delache, M. Surenaud, Mathilde Galhaut et al. · 2021 · bioRxiv
  65. Ad26.COV2.S Prevents SARS-CoV-2 Induced Pathways of Inflammation and Thrombosis in Hamsters
    Malika Aid, S. Vidal, C. Piedra-Mora, Sarah Ducat, Chi N. Chan, S. Bondoc, Al Colarusso, C. Starke, M. Nekorchuk, K. Busman-Sahay et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Effect of Covid-19 on Fintech
    Fintech, Lohitha, D. Harish · 2021
  67. SARS-CoV-2: A Professional and social gamechanger - Medical and dental aspects.
    B. P. F. de Almeida Gomes, R. Arruda-Vasconcelos, L. Louzada, Rebecca Figueiredo de Almeida-Gomes, A. de-Jesus-Soares, Luciana Montalvão Gois Figueiredo de Almeida, E. Baldacci · 2021 · Brazilian Dental Journal
  68. Targeting Mononuclear Phagocytes to Treat COVID-19
    Brandt D. Pence, T. Cory · 2021 · IntechOpen eBooks
  69. SARS-CoV-2 Immunoglobulin g (IgG) Kinetics in Healthcare Workers and Their Close Contacts Reduced Risk of Re-infection: South-East Asian Region
    M. Daga, G. Mawari, V. Karra, Meghachandra M. Singh, S. Chand, J. Aarthi, R. V., M. Jha, Amrapali Kunwar, Sweety Mehra · 2021
  70. Combination of airway pressure release ventilation with inverted inspiration-exhalation ratio and low-flow CO2 removal devices with renal replacement therapy in refractory hypoxemia
    A. González-Castro, P. Acha, J. C. Rodríguez-Borregán, Y. Peñasco, C. Blanco Huelga, E. Fito · 2021 · Medicina Intensiva
  71. COVID-19 Vaccinated Individuals Can Be a Source of SARS-CoV-2 Transmission—A Systematic Review
    G. Kampf · 2021 · Hygiene
  72. Development of leading first-generation vaccines against SARS-CoV-2
    P. Perera, L. Perera · 2021 · Microbes and infection
  73. КОРОНАВІРУСНА ХВОРОБА(COVID-19). ВИКЛИКИ ТА ПЕРСПЕКТИВИ СПЕЦИФІЧНОЇ ДІАГНОСТИКИ
    K. Gumeniuk, Данило Дубина, О. О. Юрченко · 2021 · Microbiology&Biotechnology
  74. Phodopus roborovskii SH101 as a systemic infection model of SARS-CoV-2
    Chong-Kai Zhai, Ming-Da Wang, Hea-Jong Chung, M. Hassan, Seungkoo Lee, Hyeon-Jin Kim, Seong-Tshool Hong · 2021 · bioRxiv
  75. Personalized Virus Load Curves of SARS-CoV-2 Infection
    T. Hillen, Carlos Contreras, J. Newby · 2021 · bioRxiv
  76. COVID-19 Reinfection and its Diagnostic Approach
    A. William, R. Kaur · 2021 · American Journal of Applied Sciences
  77. Animal species in SARS-CoV-2 infection
    K. Yeşilbağ, G. Aytoğu · 2020 · Eurasian Journal of Veterinary Sciences
  78. Rapid evaluation of neutralizing antibodies in COVID-19 patients
    Ping-Ping Zhang, Bai-Sheng Li, Wei Min, Xiao-Hui Wang, Zhen-Cui Li, Yong Zhao, Huan Zhang, Min Jiang, Huan-Ying Zheng, Chao Yang et al. · 2020 · medRxiv
  79. Systematic examination of T cell responses to SARS-CoV-2 versus influenza virus reveals distinct inflammatory profile
    J. Law, W. Koh, P. Budylowski, Jonah Lin, Feng Yue, K. Abe, B. Rathod, M. Girard, Zhi-Jie Li, J. Rini et al. · 2020 · medRxiv
  80. Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing
    T. Watts, Yoojin Choi, A. Odutayo, G. Evans, D. Fisman, A. McGeer, S. Mubareka, Samir N. Paterl, P. Jüni · 2020
  81. Discrete SIRIR modelling using empirical infection data shows that SARS-CoV-2 infection provides short-term immunity
    Andrew McMahon, Nicole C. Robb · 2020 · medRxiv
  82. La respuesta inmune frente a SARS-CoV-2, ¿un arma de doble filo?
    J. Pertejo · 2020 · Revista de Investigación y Educación en Ciencias de la Salud (RIECS)
  83. Is it possible to suspend the spread of an epidemic infection? The dynamic Monte Carlo approach
    G. Burlak · 2020
  84. SARS-CoV-2 Infection and Antibody-Dependent Enhancement
    A. Baştuğ, H. Bodur · 2021 · Understanding COVID-19: The Role of Computational Intelligence
  85. Investigating Chronic Post-Infection and Post-Injury Symptom Syndromes: Clinical Outcomes, Biological Pathways, and Potential Links to Neurodegenerative Disease
    Allison N. Grossberg · 2024